Forest Labs
Executive Summary
Firm is asking FDA to add nitroglycerin 10 mg buccal tabs to DESI list for ANDA-eligible drugs. Request is based on the conditional approval of Forest's Sustachron (nitroglycerin) 5 mg buccal and 10 mg tabs and studies previously submitted that have shown the drug "to be effective in treating angina".